Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema-Reference-Cited by-同舟云学术

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema

Published:2019-08 Issue:8 Volume:126 Page:1155-1170
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Sahni Jayashree,Patel Sunil S.,Dugel Pravin U.,Khanani Arshad M.,Jhaveri Chirag D.,Wykoff Charles C.^ORCID,Hershberger Vrinda S.,Pauly-Evers Meike,Sadikhov Shamil,Szczesny Piotr,Schwab Dietmar,Nogoceke Everson,Osborne Aaron^ORCID,Weikert Robert,Fauser Sascha

Funder

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

Ophthalmology

Reference42 articles.

1. Global estimates of diabetes prevalence for 2013 and projections for 2035;Guariguata;Diabetes Res Clin Pract,2014

2. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review;Ting;Clin Exp Ophthalmol,2016

3. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss;Lee;Eye Vis (Lond),2015

4. Anti-vascular endothelial growth factor therapy for diabetic macular edema;Boyer;Ther Adv Endocrinol Metab,2013

5. Diabetic retinopathy;Fong;Diabetes Care,2004

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive assessment of the impact of intravitreal faricimab on retinal diseases: A systematic review, meta-analysis, and trial sequential analysis;Pharmacological Research;2024-10

2. Targeting pericyte retention in Diabetic Retinopathy: a review;Annals of Medicine;2024-09-13

3. Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration;International Ophthalmology;2024-09-05

4. Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease;Ophthalmology Science;2024-09

5. Dual pathway inhibition with faricimab for previously treated neovascular age-related macular degeneration and diabetic macular oedema: guidance from a UK panel of retina specialists;Eye;2024-08-30